207 related articles for article (PubMed ID: 22812444)
1. Synthesis and evaluation of a peptide targeted small molecular Gd-DOTA monoamide conjugate for MR molecular imaging of prostate cancer.
Wu X; Burden-Gulley SM; Yu GP; Tan M; Lindner D; Brady-Kalnay SM; Lu ZR
Bioconjug Chem; 2012 Aug; 23(8):1548-56. PubMed ID: 22812444
[TBL] [Abstract][Full Text] [Related]
2. MR molecular imaging of prostate cancer with a peptide-targeted contrast agent in a mouse orthotopic prostate cancer model.
Tan M; Burden-Gulley SM; Li W; Wu X; Lindner D; Brady-Kalnay SM; Gulani V; Lu ZR
Pharm Res; 2012 Apr; 29(4):953-60. PubMed ID: 22139536
[TBL] [Abstract][Full Text] [Related]
3. MR molecular imaging of prostate cancer with a small molecular CLT1 peptide targeted contrast agent.
Wu X; Lindner D; Yu GP; Brady-Kalnay S; Lu ZR
J Vis Exp; 2013 Sep; (79):. PubMed ID: 24056726
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and evaluation of a targeted nanoglobular dual-modal imaging agent for MR imaging and image-guided surgery of prostate cancer.
Tan M; Ye Z; Lindner D; Brady-Kalnay SM; Lu ZR
Pharm Res; 2014 Jun; 31(6):1469-76. PubMed ID: 23471641
[TBL] [Abstract][Full Text] [Related]
5. Peptide-targeted Nanoglobular Gd-DOTA monoamide conjugates for magnetic resonance cancer molecular imaging.
Tan M; Wu X; Jeong EK; Chen Q; Lu ZR
Biomacromolecules; 2010 Mar; 11(3):754-61. PubMed ID: 20131758
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and evaluation of a polydisulfide with Gd-DOTA monoamide side chains as a biodegradable macromolecular contrast agent for MR blood pool imaging.
Ye Z; Wu X; Tan M; Jesberger J; Grisworld M; Lu ZR
Contrast Media Mol Imaging; 2013; 8(3):220-8. PubMed ID: 23606425
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and evaluation of globular Gd-DOTA-monoamide conjugates with precisely controlled nanosizes for magnetic resonance angiography.
Kaneshiro TL; Jeong EK; Morrell G; Parker DL; Lu ZR
Biomacromolecules; 2008 Oct; 9(10):2742-8. PubMed ID: 18771313
[TBL] [Abstract][Full Text] [Related]
8. Peptide targeted high-resolution molecular imaging of prostate cancer with MRI.
Wu X; Yu G; Lindner D; Brady-Kalnay SM; Zhang Q; Lu ZR
Am J Nucl Med Mol Imaging; 2014; 4(6):525-36. PubMed ID: 25250202
[TBL] [Abstract][Full Text] [Related]
9. An effective targeted nanoglobular manganese(II) chelate conjugate for magnetic resonance molecular imaging of tumor extracellular matrix.
Tan M; Wu X; Jeong EK; Chen Q; Parker DL; Lu ZR
Mol Pharm; 2010 Aug; 7(4):936-43. PubMed ID: 20481565
[TBL] [Abstract][Full Text] [Related]
10. A neutral polydisulfide containing Gd(III) DOTA monoamide as a redox-sensitive biodegradable macromolecular MRI contrast agent.
Ye Z; Zhou Z; Ayat N; Wu X; Jin E; Shi X; Lu ZR
Contrast Media Mol Imaging; 2016; 11(1):32-40. PubMed ID: 26218648
[TBL] [Abstract][Full Text] [Related]
11. A peptide targeted contrast agent specific to fibrin-fibronectin complexes for cancer molecular imaging with MRI.
Ye F; Wu X; Jeong EK; Jia Z; Yang T; Parker D; Lu ZR
Bioconjug Chem; 2008 Dec; 19(12):2300-3. PubMed ID: 19053180
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and Assessment of Peptide Gd-DOTA Conjugates Targeting Extradomain B Fibronectin for Magnetic Resonance Molecular Imaging of Prostate Cancer.
Li Y; Han Z; Roelle S; DeSanto A; Sabatelle R; Schur R; Lu ZR
Mol Pharm; 2017 Nov; 14(11):3906-3915. PubMed ID: 28976766
[TBL] [Abstract][Full Text] [Related]
13. Peptide targeted tripod macrocyclic Gd(III) chelates for cancer molecular MRI.
Zhou Z; Wu X; Kresak A; Griswold M; Lu ZR
Biomaterials; 2013 Oct; 34(31):7683-93. PubMed ID: 23863450
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and evaluation of nanoglobular macrocyclic Mn(II) chelate conjugates as non-gadolinium(III) MRI contrast agents.
Tan M; Ye Z; Jeong EK; Wu X; Parker DL; Lu ZR
Bioconjug Chem; 2011 May; 22(5):931-7. PubMed ID: 21473650
[TBL] [Abstract][Full Text] [Related]
15. Targeted Contrast Agents for Magnetic Resonance Molecular Imaging of Cancer.
Lu ZR; Laney V; Li Y
Acc Chem Res; 2022 Oct; 55(19):2833-2847. PubMed ID: 36121350
[TBL] [Abstract][Full Text] [Related]
16. Integrin α6-Targeted Magnetic Resonance Imaging of Hepatocellular Carcinoma in Mice.
Zhang Y; Zhao J; Cai J; Ye JC; Xiao YT; Mei Y; Zeng MS; Xie CM; Jiang Y; Feng GK
Mol Imaging Biol; 2020 Aug; 22(4):864-872. PubMed ID: 31792839
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]